Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
First Shanghai Securities is a prominent financial services firm based in Hong Kong and a core subsidiary of First Shanghai Investments Limited. The company offers a wide array of financial products and services, including securities brokerage, wealth management, and corporate finance advisory, primarily targeting the Greater China market. Although the firm provides investment research and analysis on the healthcare and biotechnology sectors, it does not engage in drug discovery or medical research itself. It is a licensed corporation under the Securities and Futures Commission of Hong Kong and serves institutional, corporate, and individual clients through its trading platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on First Shanghai Securities.